共 50 条
- [1] Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01): : 234 - 241
- [3] Long-term-treatment of secondary hyperparathyroidism (HPT) with the calcimimetic cinacalcet HCl. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 463A - 464A
- [4] Impact of Vitamin D Dose on Biochemical Parameters in Patients with Secondary Hyperparathyroidism Receiving Cinacalcet NEPHRON CLINICAL PRACTICE, 2009, 112 (01): : C41 - C50
- [5] Cinacalcet HCI is an effective primary therapy for the management of secondary hyperparathyroidism (HPT). JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 460A - 461A
- [7] Cinacalcet HCl controls secondary hyperparathyroidism (HPT) in dialysis patients regardless of disease severity. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 463A - 463A
- [9] Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients World Journal of Surgery, 2022, 46 : 813 - 819